Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:557207rdf:typepubmed:Citationlld:pubmed
pubmed-article:557207lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:557207lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:557207lifeskim:mentionsumls-concept:C0003123lld:lifeskim
pubmed-article:557207lifeskim:mentionsumls-concept:C0011812lld:lifeskim
pubmed-article:557207lifeskim:mentionsumls-concept:C0024977lld:lifeskim
pubmed-article:557207lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:557207lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:557207lifeskim:mentionsumls-concept:C1527240lld:lifeskim
pubmed-article:557207pubmed:issue1lld:pubmed
pubmed-article:557207pubmed:dateCreated1977-4-25lld:pubmed
pubmed-article:557207pubmed:abstractTextThe effect of an imidazo-isoindole derivative (mazindol) upon motor and feeding activity and two different avoidance behaviours have been compared with those of d-amphetamine in rats. It was found that both drugs depress feeding activity in a dose-related manner and increase the motor activity of the animals. However, the ratio of the lowest motility-increasing dose and the lowest appetite suppressant dose is 0.5 for d-amphetamine and 2 for mazindol. Mazindol, like d-amphetamine, caused a stereotyped behaviour in rats when given in very high doses, but the range between the anorexic and the stereotyped behaviour dose is much higher for mazindol than for d-amphetamine. The shuttle-box avoidance behaviour suppressed by tetrabenazine is completely restored by d-amphetamine and partially by mazindol. Lever-pressing avoidance suppressed by tetrabenazine is restored by d-amphetamine while mazindol at the doses used is ineffective. It is concluded that mazindol could be an anorexic agent better suited than d-amphetamine for clinical use.lld:pubmed
pubmed-article:557207pubmed:languageenglld:pubmed
pubmed-article:557207pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:557207pubmed:citationSubsetIMlld:pubmed
pubmed-article:557207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:557207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:557207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:557207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:557207pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:557207pubmed:statusMEDLINElld:pubmed
pubmed-article:557207pubmed:issn0031-7012lld:pubmed
pubmed-article:557207pubmed:authorpubmed-author:BabbiniMMlld:pubmed
pubmed-article:557207pubmed:authorpubmed-author:GaiardiMMlld:pubmed
pubmed-article:557207pubmed:authorpubmed-author:BartolettiMMlld:pubmed
pubmed-article:557207pubmed:issnTypePrintlld:pubmed
pubmed-article:557207pubmed:volume15lld:pubmed
pubmed-article:557207pubmed:ownerNLMlld:pubmed
pubmed-article:557207pubmed:authorsCompleteYlld:pubmed
pubmed-article:557207pubmed:pagination46-56lld:pubmed
pubmed-article:557207pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-H...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-A...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-R...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-I...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-M...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-D...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-B...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-A...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-T...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-A...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-M...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-F...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-S...lld:pubmed
pubmed-article:557207pubmed:meshHeadingpubmed-meshheading:557207-M...lld:pubmed
pubmed-article:557207pubmed:year1977lld:pubmed
pubmed-article:557207pubmed:articleTitleAnorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.lld:pubmed
pubmed-article:557207pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:557207pubmed:publicationTypeComparative Studylld:pubmed